Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Neogenomics Inc (NEO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,184,596
  • Shares Outstanding, K 81,640
  • Annual Sales, $ 258,610 K
  • Annual Income, $ -850 K
  • 36-Month Beta 0.58
  • Price/Sales 4.58
  • Price/Cash Flow 30.39
  • Price/Book 7.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 0.01
  • Number of Estimates 3
  • High Estimate 0.01
  • Low Estimate 0.01
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +150.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.05 +8.81%
on 09/06/18
14.88 -4.57%
on 09/19/18
+0.80 (+5.97%)
since 08/21/18
3-Month
11.87 +19.63%
on 08/10/18
15.00 -5.33%
on 08/06/18
+0.28 (+2.01%)
since 06/21/18
52-Week
7.08 +100.56%
on 02/06/18
15.00 -5.33%
on 08/06/18
+3.28 (+30.04%)
since 09/21/17

Most Recent Stories

More News
Relatively Good Performance Detected in Shares of Luminex Corp in the Life Sciences Tools & Services Industry (LMNX , FLDM , NEO , QGEN , PRAH )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

LMNX : 29.35 (-1.54%)
NEO : 14.20 (-2.14%)
FLDM : 7.86 (-4.15%)
Relatively Good Performance Detected in Shares of Neogenomics Inc in the Life Sciences Tools & Services Industry (NEO , A , TMO , ILMN , CRL )

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

A : 70.72 (-0.58%)
TMO : 243.49 (+0.41%)
NEO : 14.20 (-2.14%)
Top 5 Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (A , PKI , NEO , WAT , QGEN )

Here are the top 5 stocks in the Life Sciences Tools & Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were...

A : 70.72 (-0.58%)
NEO : 14.20 (-2.14%)
PKI : 96.61 (+0.03%)
Top 5 Companies in the Life Sciences Tools & Services Industry with the Best Relative Performance (NEO , CRL , LMNX , BRKR , A )

We looked at the Life Sciences Tools & Services industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength....

LMNX : 29.35 (-1.54%)
NEO : 14.20 (-2.14%)
CRL : 128.41 (-0.40%)
Relatively Good Performance Detected in Shares of Neogenomics Inc in the Life Sciences Tools & Services Industry (NEO , QGEN , CBM , PRAH , ILMN )

Below are the top five companies in the Life Sciences Tools & Services industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks...

NEO : 14.20 (-2.14%)
CBM : 61.20 (-3.32%)
NeoGenomics Announces Pricing on Public Offering of Common Stock

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today announced the pricing of its underwritten public offering of 9,800,000 shares of its common stock at...

NEO : 14.20 (-2.14%)
Uptrend Call Working As Neogenomics Inc Stock Rises 71.9% (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on February 22nd, 2018 at $8.26. In approximately 6 months, Neogenomics Inc has returned 71.90% as of today's recent price of $14.19.

NEO : 14.20 (-2.14%)
67.1% Return Seen to Date on SmarTrend Neogenomics Inc Call (NEO)

SmarTrend identified an Uptrend for Neogenomics Inc (NASDAQ:NEO) on February 22nd, 2018 at $8.26. In approximately 5 months, Neogenomics Inc has returned 67.05% as of today's recent price of $13.79.

NEO : 14.20 (-2.14%)
EBS vs. NEO: Which Stock Should Value Investors Buy Now?

EBS vs. NEO: Which Stock Is the Better Value Option?

EBS : 65.96 (-0.06%)
NEO : 14.20 (-2.14%)
Breakfast Technical Briefing on TrovaGene and Three Other Additional Medical Research Stocks

Stock Research Monitor: FMI, NEO, and STIM

FMI : 136.95 (-0.04%)
NEO : 14.20 (-2.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade NEO with:

Business Summary

NeoGenomics, Inc. is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing, the fastest growing segment of the laboratory industry. The company's testing services include cytogenetics, fluorescence in-situ hybridization, flow cytometry, morphology...

See More

Key Turning Points

2nd Resistance Point 14.81
1st Resistance Point 14.50
Last Price 14.20
1st Support Level 13.93
2nd Support Level 13.67

See More

52-Week High 15.00
Last Price 14.20
Fibonacci 61.8% 11.97
Fibonacci 50% 11.04
Fibonacci 38.2% 10.11
52-Week Low 7.08

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar